When comparing individuals with neuro-PCC with control participants who had never had COVID-19, we found no evidence of overt neuroinflammation (normal CSF cell count, inflammatory cytokines) or blood-brain barrier dysfunction (normal albumin ratio), suggesting that persistent central nervous system immune activation is not a primary driver of neurological long COVID-19. The gene discussed is ALB; the disease is COVID-19.